• Improving
    Outcomes in
    Solid Tumor
    Cancer Treatment

    BIO300
    A New Class of Cancer Drug.
    Kills Cancer Cells.  Protects Normal Tissue.

  • Keeping America Safe

    BIO300
    Protecting Civilians, First Responders and Our Military
    from Nuclear Accidents and Terrorism.

Humanetics News

02.12.18

Humanetics Corporation Presents at 2018 BIO CEO and Investor Conference
Read More

01.30.18

Humanetics Corporation Presents Data on Drug to Protect Cardiac Cells Against Toxicity From Space-Like Radiation

Read More

01.11.18

Vice Admiral Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins Humanetics Medical advisory board

Read More

10.31.17

Humanetics Presents Data for Cancer Drug

Read More

10.10.17

Humanetics Receives New Grant from NASA

Read More

09.26.17

Humanetics Receives $3.8 Million Grant from Department of Defense

Read More

09.12.17

Humanetics Receives Patent for Cancer Drug

Read more

08.22.17

Humanetics to Present at Department of Defense Scientific Meeting

Read more